HLA-G and colorectal carcinoma: In CRC patients, sHLA-G (median: 36.8 U/ml; range: 1.6 – 531.0) were significantly increased compared with normal controls (median: 25.4 U/ml; range: 3.6–97.1; p = 0.009).